107 This selleck chemical decellularization phase of tissue-engineered heart valves was demonstrated not to alter #kinase inhibitor Ruxolitinib randurls[1|1|,|CHEM1|]# the collagen structure or tissue strength; it also favored valve performance when compared to their cell-populated counterparts and could provide largely available

off-the-shelf homologous scaffolds suitable for reseeding with autologous cells. Key requirements and properties of those substrates were then discussed in the light of current trends toward designing biologically inspired microenvironments for in situ tissue engineering purposes.108 The concept of in situ tissue engineering, i.e. neotissue regeneration Inhibitors,research,lifescience,medical without the use of seeded cells, could solve the disadvantages of using any cell source and achieve a versatile and easier cell-free protocol.109 The evaluation of in situ tissue engineering vasculature (iTEV)

by implantation of scaffolds made of polyglycolide knitted fibers and an L-lactide and -caprolactone co-polymer sponge Inhibitors,research,lifescience,medical in the inferior vena cava of a canine model supported this concept by demonstrating a native tissue-like histological regeneration, with acceptable biomechanical characteristics.110 More recently, hundreds of polymers were comprehensively assessed for tissue engineering of cardiac valves, using polymer microarray technology.111 Biomechanical tests with real-time displacement and strain mapping were also Inhibitors,research,lifescience,medical recently reported to quantify biomechanical and biochemical properties of semilunar heart valve tissues, and potentially facilitate the development of tissue-engineered heart valves.112 The role of substrate stiffness in modulating the gene expression and phenotype of neonatal cardiomyocytes Inhibitors,research,lifescience,medical in vitro113 or seeded human bone-marrow stem cells,114 on the one hand, and in modulating the activation of valvular interstitial

Inhibitors,research,lifescience,medical cells,115 on the other hand, demonstrated the importance of the mechanical properties of materials used for valve repair or for engineering valve tissue.116 Electrospinning appears in the literature as a promising technology to produce scaffolds for cardiovascular tissue engineering. Amoroso et al. evaluated the effect of processing variables and secondary fiber populations on the microstructure and the tensile and bending mechanics of Drug_discovery electro-spun biodegradable polyurethane scaffolds for heart valve tissue engineering.117 Computational tools were developed in order to describe and predict the mechanical behavior of electrospun valve-shaped scaffolds characterized by different microstructures and showed that a pronounced degree of anisotropy was necessary to reproduce the deformation patterns observed in the native heart valve.118 In the emerging field of tissue engineering and regenerative medicine, different design strategies were evaluated to promote the development and evaluation of improved tissue engineering scaffolds.